Undecimal Bio Seed: €16M

Oct 12, 2026Public sources — Collected from public sources, not yet cross-checked.

Undecimal Bio raised €16 million (about $17.9 million) in a seed round led by 4BIO Capital and IQ Capital, announced Oct. 12.

Facts

Company: Undecimal Bio
Amount: €16 million (about $17.9 million)
Currency: EUR
Stage: Seed
Announced: Oct 12, 2026
Instrument: Equity
FX rate: 1 EUR = 1.1188 USD on Oct 12, 2026

Investors

Led by: 4BIO Capital IQ Capital
Participants: Verve Ventures Harel Tech Entree Capital Kerna Ventures Saras Capital

Use of funds

Expand the DELiveri platform, progress renovascular programmes, and enable team expansion.

As stated by the company.

Sources

1.Undecimal Bio lands €16 million to develop targeted RNA medicines beyond the liver — EU-Startups, Oct 13, 2026

Public sources — Collected from public sources, not yet cross-checked.Last verified Oct 15, 2026